Alerts will be sent to your verified email
Verify EmailBLISSGVS
Bliss GVS Pharma
|
Lincoln Pharma
|
Ind-Swift
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
2.57 % | 3.1 % | n/a |
Financials
|
|||
5 yr Average ROE
|
10.14 % | 16.41 % | 30.85 % |
5yr average Equity Multiplier
|
1.36 | 1.35 | -1.62 |
5yr Average Asset Turnover Ratio
|
0.7 | 0.87 | 0.48 |
5yr Avg Net Profit Margin
|
10.24 % | 14.05 % | -45.85 % |
Price to Book
|
1.12 | 2.26 | 0.0 |
P/E
|
14.37 | 14.36 | 8.15 |
5yr Avg Cash Conversion Cycle
|
162.62 Days | 10.4 Days | -212.7 Days |
Inventory Days
|
51.37 Days | 41.92 Days | 74.98 Days |
Days Receivable
|
187.07 Days | 86.41 Days | 85.13 Days |
Days Payable
|
75.42 Days | 100.81 Days | 267.01 Days |
5yr Average Interest Coverage Ratio
|
15.0 | 44.62 | -6.47 |
5yr Avg ROCE
|
17.11 % | 20.85 % | -66.14 % |
5yr Avg Operating Profit Margin
|
21.12 % | 21.16 % | -5.79 % |
5 yr average Debt to Equity
|
0.14 | 0.03 | -2.08 |
5yr CAGR Net Profit
|
-4.95 % | 8.4 % | n/a |
5yr Average Return on Assets
|
7.4 % | 12.15 % | -16.74 % |
Shareholdings
|
|||
Promoter Holding
|
34.97 % | 49.53 % | 55.58 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 42.81 % |
Change in Promoter Holding (3 Yrs)
|
1.66 % | 12.27 % | 0.03 % |
Change in Mutual Fund Holding (3 Yrs)
|
-0.03 % | 0.0 | 0.0 |
Bliss GVS Pharma
|
Lincoln Pharma
|
Ind-Swift
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|